CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the Rodman & Renshaw 8th Annual Healthcare Conference to be held at the Palace Hotel in New York City. The presentation will begin at 9:55 a.m. (ET) on Monday, November 6, 2006.
